| Metric | FY2020 | FY2019 | FY2018 |
|---|---|---|---|
| Revenue | $21.8M-49.3% | $43.0M+200.0% | $14.3M |
| Research and development | $108.4M+61.3% | $67.2M+48.7% | $45.2M |
| General and administrative | $38.3M+40.3% | $27.3M+111.2% | $12.9M |
| Total operating expenses | $146.7M+55.2% | $94.5M+62.6% | $58.1M |
| Loss from operations | -$124.9M-142.3% | -$51.5M-17.6% | -$43.8M |
| Other income | $2.0M+39.6% | $1.4M+1297.4% | $103K |
| Change in fair value of preferred unit warrant | $0 | $0+100.0% | -$194K |
| Interest income | $3.6M-21.3% | $4.6M+84.5% | $2.5M |
| Interest expense | -$65K+24.0% | -$86K-49.0% | -$57K |
| Total other income | $5.5M-6.5% | $5.9M+154.4% | $2.3M |
| Loss from equity method investment | $0+100.0% | -$24.7M | $0 |
| Net loss | -$119.3M-69.8% | -$70.3M-69.5% | -$41.5M |
| Change in redemption value of redeemable preferred units | $0 | $0+100.0% | -$198.4M |
| Net loss attributable to common shares | -$119.3M-69.8% | -$70.3M+70.7% | -$239.8M |
| Net loss per common share, basic and diluted | -$3.02-41.8% | -$2.13+91.6% | -$25.45 |
| Weighted average common shares outstanding, basic and diluted | 39.5M+20.1% | 32.9M+249.4% | 9.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.